Skip to main content
Clinical Trials/ITMCTR2000003345
ITMCTR2000003345
Recruiting
Phase 2

Prospective Randomized Controlled Clinical Study for Lung Health Beverage in Preventing Radiotherapy-Related Lung Diseases in Locally Advanced Esophageal Cancer

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine0 sitesTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. pathological confirmed of esophageal squamous cell carcinoma;
  • 2\. TNM stage T3\-4N0M0, TxN1\-2M0, TxNxM1a (cervical lymph node metastasis);
  • 3\. Patients with expected survival \>\=6 months;
  • 4\. Patients aged 18 to 80 years;
  • 5\. Patients with ECOG 0\-1;
  • 6\. Patients with sufficient main organ function
  • (1\) Hemopoietic function: hemoglobin \>\= 100g/L, platelet \>\= 90 x 10^9/L, neutrophil \>\= 1\.5x10^9/L;
  • (2\) Renal function: serum creatinine SCR \< 1\.5 ULN;
  • (3\) Liver function: ALT and AST \< ULN one point five Times, bilirubin \<1\.5 x ULN;
  • 7\. The patient must sign the informed consent of receiving concurrent radiotherapy and chemotherapy.

Exclusion Criteria

  • 1\. Patients who have previously suffered from or complicated with other malignant tumors (except melanoma skin tumors) and whose diseases are not controlled or cured (depending on the disease type of the primary tumor);
  • 2\. Patients who have previously treated with thoracic radiotherapy;
  • 3\. Patients with congenital or acquired immune deficiency;
  • 4\. HIV positive patients, including those who have received antiretroviral therapy; chronic hepatitis B, virus replication period; active period of hepatitis C;
  • 5\. Pregnancy (confirmed by serum or urine beta\- hCG test) or lactation period;
  • 6\. The general condition of the patients was poor, KPS \< 70;
  • 7\. Patients have conditions that researchers believe may increase the risk of treatment or have serious uncontrollable complications.

Outcomes

Primary Outcomes

Not specified

Similar Trials